-
Je něco špatně v tomto záznamu ?
Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides
J. Snášel, P. Nauš, J. Dostál, A. Hnízda, J. Fanfrlík, J. Brynda, A. Bourderioux, M. Dušek, H. Dvořáková, J. Stolaříková, H. Zábranská, R. Pohl, P. Konečný, P. Džubák, I. Votruba, M. Hajdúch, P. Rezáčová, V. Veverka, M. Hocek, I. Pichová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25259627
DOI
10.1021/jm500497v
Knihovny.cz E-zdroje
- MeSH
- adenin analogy a deriváty chemie MeSH
- adenosinkinasa antagonisté a inhibitory chemie metabolismus MeSH
- adenosintrifosfát metabolismus MeSH
- antituberkulotika chemie farmakologie MeSH
- konformace proteinů MeSH
- krystalografie rentgenová MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- Mycobacterium tuberculosis účinky léků enzymologie MeSH
- nukleární magnetická rezonance biomolekulární MeSH
- preklinické hodnocení léčiv MeSH
- ribonukleosidy chemie farmakologie MeSH
- vazebná místa MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Adenosine kinase (ADK) from Mycobacterium tuberculosis (Mtb) was selected as a target for design of antimycobacterial nucleosides. Screening of 7-(het)aryl-7-deazaadenine ribonucleosides with Mtb and human (h) ADKs and testing with wild-type and drug-resistant Mtb strains identified specific inhibitors of Mtb ADK with micromolar antimycobacterial activity and low cytotoxicity. X-ray structures of complexes of Mtb and hADKs with 7-ethynyl-7-deazaadenosine showed differences in inhibitor interactions in the adenosine binding sites. 1D (1)H STD NMR experiments revealed that these inhibitors are readily accommodated into the ATP and adenosine binding sites of Mtb ADK, whereas they bind preferentially into the adenosine site of hADK. Occupation of the Mtb ADK ATP site with inhibitors and formation of catalytically less competent semiopen conformation of MtbADK after inhibitor binding in the adenosine site explain the lack of phosphorylation of 7-substituted-7-deazaadenosines. Semiempirical quantum mechanical analysis confirmed different affinity of nucleosides for the Mtb ADK adenosine and ATP sites.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023002
- 003
- CZ-PrNML
- 005
- 20240611141250.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/jm500497v $2 doi
- 035 __
- $a (PubMed)25259627
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic , Flemingovo nam. 2, 16610 Prague 6, Czech Republic.
- 245 10
- $a Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides / $c J. Snášel, P. Nauš, J. Dostál, A. Hnízda, J. Fanfrlík, J. Brynda, A. Bourderioux, M. Dušek, H. Dvořáková, J. Stolaříková, H. Zábranská, R. Pohl, P. Konečný, P. Džubák, I. Votruba, M. Hajdúch, P. Rezáčová, V. Veverka, M. Hocek, I. Pichová,
- 520 9_
- $a Adenosine kinase (ADK) from Mycobacterium tuberculosis (Mtb) was selected as a target for design of antimycobacterial nucleosides. Screening of 7-(het)aryl-7-deazaadenine ribonucleosides with Mtb and human (h) ADKs and testing with wild-type and drug-resistant Mtb strains identified specific inhibitors of Mtb ADK with micromolar antimycobacterial activity and low cytotoxicity. X-ray structures of complexes of Mtb and hADKs with 7-ethynyl-7-deazaadenosine showed differences in inhibitor interactions in the adenosine binding sites. 1D (1)H STD NMR experiments revealed that these inhibitors are readily accommodated into the ATP and adenosine binding sites of Mtb ADK, whereas they bind preferentially into the adenosine site of hADK. Occupation of the Mtb ADK ATP site with inhibitors and formation of catalytically less competent semiopen conformation of MtbADK after inhibitor binding in the adenosine site explain the lack of phosphorylation of 7-substituted-7-deazaadenosines. Semiempirical quantum mechanical analysis confirmed different affinity of nucleosides for the Mtb ADK adenosine and ATP sites.
- 650 _2
- $a adenin $x analogy a deriváty $x chemie $7 D000225
- 650 _2
- $a adenosinkinasa $x antagonisté a inhibitory $x chemie $x metabolismus $7 D000248
- 650 _2
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 _2
- $a antituberkulotika $x chemie $x farmakologie $7 D000995
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a preklinické hodnocení léčiv $7 D004353
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x enzymologie $7 D009169
- 650 _2
- $a nukleární magnetická rezonance biomolekulární $7 D019906
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a ribonukleosidy $x chemie $x farmakologie $7 D012263
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nauš, Petr
- 700 1_
- $a Dostál, Jiří
- 700 1_
- $a Hnízda, Aleš $7 xx0207773
- 700 1_
- $a Fanfrlík, Jindřich
- 700 1_
- $a Brynda, Jiří
- 700 1_
- $a Bourderioux, Aurelie
- 700 1_
- $a Dušek, Michal $7 xx0318257
- 700 1_
- $a Dvořáková, Hana
- 700 1_
- $a Stolaříková, Jiřina
- 700 1_
- $a Zábranská, Helena
- 700 1_
- $a Pohl, Radek
- 700 1_
- $a Konečný, Petr
- 700 1_
- $a Džubák, Petr
- 700 1_
- $a Votruba, Ivan
- 700 1_
- $a Hajdúch, Marián
- 700 1_
- $a Rezáčová, Pavlína
- 700 1_
- $a Veverka, Václav
- 700 1_
- $a Hocek, Michal
- 700 1_
- $a Pichová, Iva
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 57, č. 20 (2014), s. 8268-79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25259627 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20240611141247 $b ABA008
- 999 __
- $a ok $b bmc $g 1083341 $s 905995
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 57 $c 20 $d 8268-79 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20150709